Leila Kushan
Biographic Data
| ID | 1935688 |
|---|---|
| NAME | Leila Kushan |
| GIVEN NAMES | Leila |
| FAMILY NAME | Kushan |
| SIGNATURE | KUSHAN L |
| AFFILIATIONS | University of California, Los Angeles |
| ORCID | 0000-0002-2650-7147 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis
Individuals at genetic and CHR-P have strikingly different patterns of substance use. Factors such as increased neurodevelopmental symptoms (lower IQ, higher rates of ASD) and poorer social functioning in 22qDel may help explain this distinction from substance use patterns observed in CHR-P individuals
Rare CNVs and phenome-wide profiling highlight brain structural divergence and phenotypical convergence
Neurobehavioral Dimensions of Prader Willi Syndrome
PWS is associated with a high prevalence of distressing psychosis-risk symptoms, which are associated with sleep disturbance. Findings indicate that self/parent-reported neurobehavioral symptoms and cognition can be assessed remotely in individuals with PWS, which has implications for future large-scale investigations of rare neurogenetic disorders
Neurobehavioral Dimensions of Prader Willi Syndrome
PWS is associated with a high prevalence of distressing psychosis-risk symptoms, which are associated with sleep disturbance. Findings indicate that self/parent-reported neurobehavioral symptoms and cognition can be assessed remotely in individuals with PWS, which has implications for future large-scale investigations of rare neurogenetic disorders
Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis
Individuals at genetic and CHR-P have strikingly different patterns of substance use. Factors such as increased neurodevelopmental symptoms (lower IQ, higher rates of ASD) and poorer social functioning in 22qDel may help explain this distinction from substance use patterns observed in CHR-P individuals
Rare CNVs and phenome-wide profiling highlight brain structural divergence and phenotypical convergence
Clinical Psychology (2 works) · Clinical Psychology (2 works) · Congenital heart defects research (2 works) · Genetics and Neurodevelopmental Disorders (2 works) · Medicine (2 works) · Psychiatry (2 works) · Psychology (2 works) · Psychosis (2 works) · Anhedonia (1 work) · Autism Spectrum Disorder Research (1 work)